CRISPR Therapeutics AG (CRISPR Therapeutics AG) Net Debt Paydown Yield % : 0.01% (As of Apr. 27, 2024)

CRISPR Therapeutics AG Net Debt Paydown Yield % Chart

CRISPR Therapeutics AG Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Net Debt Paydown Yield %		Get a 7-Day Free Trial					-	-0.09	-2.02	-2.23	0.01

CRISPR Therapeutics AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Debt Paydown Yield %	Get a 7-Day Free Trial															-2.23	-0.76	-0.34	-0.16	0.01

Competitive Comparison of CRISPR Therapeutics AG's Net Debt Paydown Yield %

For the Biotechnology subindustry, CRISPR Therapeutics AG's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CRISPR Therapeutics AG's Net Debt Paydown Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CRISPR Therapeutics AG's Net Debt Paydown Yield % distribution charts can be found below:

* The bar in red indicates where CRISPR Therapeutics AG's Net Debt Paydown Yield % falls into.

CRISPR Therapeutics AG Net Debt Paydown Yield % Calculation

CRISPR Therapeutics AG's Net Debt Paydown Yield % for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

CRISPR Therapeutics AG  (NAS:CRSP) Net Debt Paydown Yield % Explanation

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.

In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.

We calculating the TTM average debt by adding up the total debt, calculated by the sum of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation, in the trailing twelve months(TTM) divided by the counts of the total debt, accoring to the company's report frequency.

CRISPR Therapeutics AG Net Debt Paydown Yield % Related Terms

Thank you for viewing the detailed overview of CRISPR Therapeutics AG's Net Debt Paydown Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

CRISPR Therapeutics AG (CRISPR Therapeutics AG) Business Description